Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...

IonQ, a leading quantum technology company, has announced a record-breaking advancement in protein folding, a critical ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The initiative, referred to as the Commissioner’s National Priority Voucher program, allows drug developers to participate in a novel FDA priority program. The program significantly shortens the FDA ...

FDA approval of VYKAT XR for hyperphagia in Prader-Willi Syndrome marks a major milestone for Soleno Therapeutics.

The Supreme Court ruled on Friday that a challenge by retailers to the Food and Drug Administration’s denial of an ...

Archeus hopes to begin a Phase I trial of the PSMA-targeted agent in metastatic, castration-resistant prostate cancer later this year.

The case centered on venue-shopping and whether the tobacco company R.J. Reynolds could appeal in the 5th Circuit appeals ...

For selected applicants, the agency plans to cut review times down to one to two months and provide "tumor board-style" ...

The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to-consumer offering.

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...